National
EXCLUSIVE: Elizabeth Warren pledges to lead on LGBT rights
Senate hopeful calls on Obama to endorse marriage equality
Elizabeth Warren at Women In Finance symposium (photo public domain)
Elizabeth Warren, who is running to unseat U.S. Sen. Scott Brown (R-Mass.), pledged to support a series of pro-LGBT initiatives and called on President Obama to endorse marriage equality in an exclusive interview with the Washington Blade on Tuesday.
Warren endorsed the idea of an executive order from President Obama that would require companies doing business with the U.S. government to have LGBT-inclusive non-discrimination policies for their workers.
“Any steps that the president can take toward non-discrimination benefit the whole country,” Warren said. “I don’t know how else to say it. It’s the right thing to do.”
The measure is sometimes referred to as the “ENDA” executive order because its effect would be similar to the Employment Non-Discrimination Act, but limited to federal contractors. The White House hasn’t said whether it will issue the directive.
Warren called on President Obama to complete his now 17-month-old “evolution” and endorse marriage equality. She also said she supports the call for a marriage equality plank in the Democratic Party platform this September.
Asked whether she wants Obama to finish evolving and support same-sex marriage, Warren chuckled and responded that was indeed her view.
“I want to see the president evolve because I believe that is right; marriage equality is morally right,” Warren said.
Warren expressed similar sentiments about the Democratic Party platform, saying it would build support for ending the anti-gay Defense of Marriage Act.
“I’d be glad to see it included in the Democratic platform,” she said. “It helps raise awareness of the impact of DOMA and it helps build support to repeal it.”
The platform committee is set to discuss language for the Democratic Party platform when it gathers for the Democratic National Convention Sept. 3 in Charlotte, N.C.
Warren, an expert on the American economy and personal finance, gained notoriety after she chaired the congressional oversight panel for the 2008 bank bailout program. She led the establishment of the Consumer Financial Protection Bureau that was set up by the 2010 Wall Street reform bill, and was a favorite among progressives to head the organization before she launched her Senate bid and Richard Courdray was recess appointed to the role.
Tico Almeida, president of Freedom to Work and among the chief advocates of the ENDA executive order, said “it makes perfect sense” for Warren to come out for the measure because it would ensure taxpayer money won’t go to work environments hostile to LGBT people
“I hope Ms. Warren will telephone President Obama and urge him to pick up his pen and sign the ‘ENDA Executive Order’ that his Justice and Labor departments have drafted and delivered to the White House for his signature,” Almeida said.
Evan Wolfson, president and founder of Freedom to Marry, also praised Warren for supporting the initiatives related to same-sex marriage and called on Obama and the Democratic Party to come into alignment with her views.
“We welcome Elizabeth Warren alongside the many other leaders, and the signers of our online petition, as we urge President Obama and the Democratic Party to stand with Presidents Clinton and Carter in the growing nationwide majority for marriage,” Wolfson said.
Warren, who’s already expressed support for DOMA repeal, also said during the interview that she would take a leadership role in efforts to repeal the 1996 anti-gay law if elected to the Senate.
“I think that DOMA is a terrible statute,” Warren said. “For forever, the federal government has permitted the states to define marriage, and now the federal government steps in and says, ‘Yeah, the states get to do it for most families, but not those families because we don’t like them.'”
If elected to the Senate, Warren would represent a state where more than 13,000 same-sex couples have been legally married. She said DOMA, which prohibits federal recognition of these unions, is “institutionalized discrimination.”
“Being a senator from Massachusetts, it’s possible not just to be a vote in the right direction, it’s possible to provide leadership,” Warren said. “I think that starts by calling out the statute on how wrong it is morally and counter to our basic legal foundation.”
Warren noted that DOMA means a same-sex couple married in Massachusetts won’t have access to federal benefits and that those with grown children, in some instances, can’t visit grandchildren in another state “without being treated during the visit as having a different marital status.”
“I think there’s already legislation pending, but it’s got to have some energy behind it and that means you’ve got to be willing to go out and talk about it — not only here in Massachusetts but around the country on national television to get out and make that case,” Warren said.
Warren conducted the interview with the Blade via phone after she visited Fenway Health, a Boston-based organization that provides health services to the LGBT community and conducts research and advocacy for LGBT health.
She called the work at Fenway Health “extraordinary” because the institute provides both health services and engages in research.
“What they see on the clinical side informs what they’re doing on the research side,” Warren said. “So they get ideas and they’re able to test them, and the two move back and forth. As a result, we have improvement in both health outcomes for those who go to the center. At the same time, developments in research help support advances in health care and other services for LGBT [people] around the country.”
Warren said the visit she paid to the institute was a reminder that community health centers are integral to providing health services. The health care reform measure President Obama signed into law in 2010 makes grants available to such institutions.
“Community health centers are very much supported by the Affordable Care Act,” Warren said. “Republicans have declared war on it — Scott Brown, my Republican opponent, and the Republican presidential candidates have said they will repeal the Affordable Care Act. That would be devastating to community health centers, not just Fenway, but community centers across the country.”
In September, the Department of Health & Human Services awarded the institute $248,000 to help create a national training and technical assistance center aimed at helping community health centers improve the health of LGBT populations.
Warren is running against Brown — a Republican senator representing a “blue” state. Brown won praise from LGBT advocates for voting in favor of “Don’t Ask, Don’t Tell” repeal in 2010, but that was only after he twice voted against defense legislation that included repeal language.
Warren said Brown’s vote on “Don’t Ask, Don’t Tell” repeal was “a good vote” and that he should be commended for it, but added she’d step up the LGBT advocacy if elected to the Senate.
“I’ll be there on every vote,” Warren said. “I’ll be there not just to provide a vote, but leadership, and I think that’s what the LGBT community really needs.”
Warren praised Rep. Tammy Baldwin (D-Wisc.), who’s running for the open seat in Wisconsin in a bid that could make her the country’s first openly gay U.S. senator.
The two have set up a joint fundraising group called the Massachusetts-Wisconsin Victory Fund, which thus far has raised $171,250, and have appeared together in a joint fundraiser in Philadelphia hosted by donor Peter Buttenwieser.
“I was delighted to do the event with Tammy,” Warren said. “We actually did a second [event] together. We were out in San Francisco with other women senators and women challengers. And I hope we’ll have more opportunities to do that. I’d really love to see Tammy get elected. I worked with Tammy before, so I’m a big fan.”
Warren criticized the Republican presidential candidates for their anti-gay views. Each of the GOP hopefuls who’ve won any states — Mitt Romney, Rick Santorum and Newt Gingrich — backs a U.S. constitutional amendment that would ban same-sex marriage throughout the country and rescind it in states like Massachusetts.
“I think their position is wrong,” Warren said. “They have a vision of America that does not represent who we are as a people and the kind of country we want to build.”
Over the course of her campaign, Warren said she’s spoken with LGBT organizations about a variety of subjects including LGBT rights, although she couldn’t immediately identify any of the groups. Earlier this month, the Human Rights Campaign endorsed her candidacy.
“We talked about health care issues, we’ve talked about economic issues, we’ve talked about justice issues — particularly on DOMA and marriage equality,” Warren said. “We’ve also had conversations that range into other areas about art, about education, about the importance of anti-bullying programs.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Reasons to be optimistic about 2026
Long-awaited ‘Pillion’ surpasses the sexy buzz
Protecting the trans community is not optional for elected allies and candidates
Trump’s ‘American people derangement syndrome’
